Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20130914014649N4Phase 3Completed
Phase 3, randomised, open-label trial of misoprostol in Therapeutic abortion (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Frequency of abortion in the first 24 hours after admission. Started Aug 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20130914014649N4.